stars 1 stars 2 stars 3

As one of the main holders of the Mediterranean Diet, Italy is rich in raw materials that can be used to benefit the human health. Our research is focused on the study of ingredients of Mediterranean origin to create a culture of prevention for today and future generations. All our processes, from research to production and marketing, are located in Italy and aim to reduce our impact on the planet and support local farmers and producers. We use a pharmaceutical approach to our nutraceutical production, delivering on the market only products that benefit of an extended research and clinical studies, we call this approach Nutrac-Etico®. We promote only on professional targets in Italy, supported by our Nutra Advisor team, experts in nutraceutical and nutrition. We are building a global presence through reliable partners in EU and non-Eu countries. Our vision is to contribute to a healthy society in a healthy planet.

ESSERRE PHARMA Questions

The ESSERRE PHARMA annual revenue was $5.7 million in 2026.

Amedeo Squillace is the CEO of ESSERRE PHARMA.

33 people are employed at ESSERRE PHARMA.

Learn More
How It Works
get free account
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups.
search page
Search the #1 Contact Database
Get contact details of over 700M profiles across 60M companies – all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
get contact page
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users